 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper129th MAINE LEGISLATURE
SECOND REGULAR SESSION-2020
Legislative Document No. 2152
S.P. 776 In Senate,  March  12, 2020
An Act  To Permit Naloxone  Possession  and Administration in  
Public and Private Schools
(AFTER  DEADLINE)
Submitted by the Department of  Education pursuant  to Joint  Rule 205.
Reference to the Committee on Education  and Cultural Affairs  suggested  and ordered  
printed.
DAREK M.  GRANT
Secretary of the Senate
Presented by Senator MILLETT of Cumberland.

Page 1 - 129LR3205(01)-11Be it enacted by the People of the State of Maine as follows:
2Sec. 1.  20-A MRSA ยง6307 is enacted to read:
3ยง6307.  Naloxone hydrochloride possession and distribution
41.  Definitions.  As used in this section, unless the context otherwise indicates, the 
5following terms have the following meanings.
6A.  "Collaborative practice agreement" means a written and signed agreement 
7between a physician licensed in this State or a school health advisor under section 
86402-A and a school nurse under section 6403-A that provides for the possession, 
9prescription, administration and distribution of naloxone hydrochloride by the 
10physician or school health advisor and administration of naloxone hydrochloride by 
11the school nurse or designated school personnel to students, staff or visitors during 
12school or a school-sponsored activity under emergency circumstances involving an 
13opioid overdose or apparent opioid overdose.
14B.  "Designated school personnel" means those employees, agents or volunteers of a 
15school administrative unit or approved private school designated by a collaborative 
16practice agreement between a physician licensed in this State or a school health 
17advisor under section 6402-A and a school nurse under 6403-A who have completed 
18the training required by the guidelines developed pursuant to subsection 8 to 
19administer naloxone hydrochloride to a student, staff member or visitor.
20C.  "Naloxone hydrochloride" means medication, in a noninjectable form, 
21administered to reverse the effects of opioids in the emergency treatment of an opioid 
22overdose.
23D.  "School" means a public or approved private school.
242.  Collaborative practice agreement; adoption authorized.  A school 
25administrative unit or an approved private school may authorize adoption of a 
26collaborative practice agreement for the purposes of stocking, possessing and 
27administering naloxone hydrochloride as provided under this section.  The administration 
28of naloxone hydrochloride in accordance with this section is not the practice of medicine.
293.  Collaborative practice agreement; authority.  A collaborative practice 
30agreement permits a physician licensed in this State or school health advisor under 
31section 6402-A to prescribe naloxone hydrochloride and direct a school nurse under 
32section 6403-A to administer naloxone hydrochloride in good faith to any student, staff 
33member or visitor experiencing an apparent opioid overdose during school or a school-
34sponsored activity or otherwise on school grounds.  Pursuant to a collaborative practice 
35agreement, a physician licensed in this State or school health advisor under section 
366402-A may authorize the school nurse under section 6403-A during school or a school-
37sponsored activity to designate designated school personnel to administer naloxone 
38hydrochloride if the school nurse is not present when a student, staff member or visitor 
39experiences a suspected opioid overdose.
Page 2 - 129LR3205(01)-114.  Collaborative practice agreement; terms and provisions.  A collaborative 
2practice agreement must include the following information:
3A.  Name and address of the school;
4B.  Identification and signatures of the physician or school health advisor under 
5section 6402-A and school nurse under section 6403-A who are parties to the 
6collaborative practice agreement, the dates the agreement is signed by each party and 
7the beginning and end dates of the period of time within which the agreement is in 
8effect; and
9C.  Any other information considered appropriate by the physician or school health 
10advisor under section 6402-A and school nurse under section 6403-A.
115.  Use of naloxone hydrochloride without a collaborative practice agreement.  If 
12a collaborative practice agreement has not been adopted pursuant to subsection 2, the 
13governing body of a school administrative unit or an approved private school may 
14authorize a school nurse under section 6403-A to:
15A.  Stock and possess naloxone hydrochloride prescribed by a legally authorized 
16individual; and
17B.  Administer naloxone hydrochloride prescribed by a legally authorized individual 
18to any student, staff member or visitor that the school nurse, based on the school 
19nurse's professional judgment, suspects to be experiencing an opioid overdose.
20The administration of naloxone hydrochloride in accordance with this subsection is not 
21the practice of medicine.
226.  Manufacturer or supplier arrangement.  A school administrative unit or an 
23approved private school may enter into an arrangement with a manufacturer of naloxone 
24hydrochloride or a 3rd-party supplier of naloxone hydrochloride to obtain naloxone 
25hydrochloride at fair market prices, reduced prices or no cost.
267.  Purchase from licensed pharmacies.  A collaborative practice agreement under 
27this section may provide that a school administrative unit or an approved private school 
28may purchase naloxone hydrochloride from a pharmacy licensed in this State.
298.  Guidelines.  By January 1, 2021, and as needed after that date, the department in 
30consultation with the Department of Health and Human Services shall develop and make 
31available to all schools guidelines for the management of opioid overdose during school 
32or a school-sponsored activity or otherwise on school grounds.  The guidelines must 
33include, but are not limited to:
34A.  Education and training for school personnel on recognition of opioid overdose, 
35rescue breathing and the administration of naloxone hydrochloride; and
36B.  Procedures for responding to opioid overdose.
Page 3 - 129LR3205(01)-11SUMMARY
2This bill provides for the administration of naloxone hydrochloride in a noninjectable 
3form to students, school staff and school visitors through collaborative practice 
4agreements between physicians licensed in this State or school health advisors and public 
5and private school nurses.
